BioXcel Therapeutics Announces $1.25M Additional Loans From Oaktree With 20% Upfront Fee; Minimum Liquidity Covenant Cut To $250K From $3M, Must Reach Repayment Or Capital Deal By August 31

Loading news article.

BioXcel Therapeutics Announces $1.25M Additional Loans From Oaktree With 20% Upfront Fee; Minimum Liquidity Covenant Cut To $250K From $3M, Must Reach Repayment Or Capital Deal By August 31 | WAPE

BioXcel Therapeutics Announces $1.25M Additional Loans From Oaktree With 20% Upfront Fee; Minimum Liquidity Covenant Cut To $250K From $3M, Must Reach Repayment Or Capital Deal By August 31

Article summary

Related companies

Comments —